The CEACAM5 (Labetuzumab Biosimilar) Monoclonal Antibody (HDBS0035) is a cutting-edge research tool for studying CEACAM5, a cell surface glycoprotein associated with cancer progression and metastasis. This antibody, developed as a biosimilar version of Labetuzumab, is produced using state-of-the-art technology to ensure high specificity and sensitivity in detecting CEACAM5 in human samples.CEACAM5, also known as carcinoembryonic antigen-related cell adhesion molecule 5, is overexpressed in various types of cancers, including colorectal, pancreatic, and lung cancer. By targeting CEACAM5, researchers can gain insight into tumor biology, progression, and potential therapeutic strategies for inhibiting cancer cell growth.
The CEACAM5 (Labetuzumab Biosimilar) Monoclonal Antibody is validated for use in various applications, including immunohistochemistry and flow cytometry, providing researchers with versatile options for studying CEACAM5 expression and localization in tumor tissues and cell lines. Its high specificity and sensitivity make it a reliable tool for cancer research and drug development aimed at targeting CEACAM5 for therapeutic purposes.
Product Name:
Labetuzumab (Anti-CEACAM5) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0035
Target:
CEACAM5
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
